Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X:
“Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study | NPJ Breast Cancer
Very nice paper on the impact of concomitant drugs in pts treated with abemaciclib using the DRUG-PIN tool.
Authors: Simone Scagnoli, Simona Pisegna, Angela Toss, Roberta Caputo, Michelino De Laurentiis, Michela Palleschi, Ugo de Giorgi, Enrico Cortesi, Agnese Fabbri, Alessandra Fabi, Ida Paris, Armando Orlandi, Giuseppe Curigliano, Carmen Criscitiello, Ornella Garrone, Gianluca Tomasello, Giuliana D’Auria, Patrizia Vici, Enrico Ricevuto, Federica Domati, Claudia Piombino, Sara Parola, Roberta Scafetta, Alessio Cirillo, Beatrice Taurelli Salimbeni, Francesca Sofia Di Lisa, Lidia Strigari, Robert Preissner, Maurizio Simmaco, Daniele Santini, Paolo Marchetti, Andrea Botticelli. ”

Source: Filippo Montemurro/X